Vein Illuminator Market Size, Growth, Share & Trends Report, 2025

Name: Vein Illuminator Market Size, Growth, Share & Trends Report, 2025 - 2030
Creator: Mordor Intelligence
License: https://www.mordorintelligence.com/privacy-policy

Vein Illuminator Market Size and Share

Market Overview

Study Period	2019 - 2030
Market Size (2025)	USD 0.3 Billion
Market Size (2030)	USD 1.04 Billion
Growth Rate (2025 - 2030)	27.80% CAGR
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	Medium
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Vein Illuminator Market (2025 - 2030) — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Vein Illuminator Market Analysis by Mordor Intelligence

The Vein Illuminator Market size is estimated at USD 0.3 billion in 2025, and is expected to reach USD 1.04 billion by 2030, at a CAGR of 27.80% during the forecast period (2025-2030). Robust growth reflects health systems’ focus on first-attempt venipuncture success, an outcome now tied to U.S. Medicare’s value-based purchasing scores. ^{[1]AccuVein Inc., “Maury Regional Health Adopts Vein Visualization as Standard of Care to Help Improve Patient Outcomes,” AccuVein, accuvein.com} Demand is amplified by aging and obese populations that make traditional vein palpation unreliable, while rising chronic-disease monitoring requires more frequent blood draws. Technology improvements in near-infrared (NIR) imaging, falling component costs, and portable form factors further accelerate adoption. Asia-Pacific’s push to localize medical-device manufacturing and China’s hospital modernization are tilting future revenue toward cost-optimized systems. Competitive pressure is intensifying as local firms introduce low-price NIR devices that undercut established brands while premium models layer on AI guidance and multi-modal imaging.

Key Report Takeaways

By technology, Near-Infrared Illumination led with 50.3% revenue share in 2024; Ultrasound-Augmented systems are projected to expand at a 31.8% CAGR through 2030.
By product type, Hand-held and Portable units held 61.2% of the vein illuminator market share in 2024, while Wearable and Clip-On Modules post the fastest 34.1% CAGR to 2030.
By application, Intravenous Access accounted for 42.7% of the vein illuminator market size in 2024; Sclerotherapy and Varicose Vein Treatment are forecast to grow at 32.5% CAGR to 2030.
By end-user, Hospitals and Clinics captured 46.1% revenue in 2024; Ambulatory Surgical Centers recorded the highest 30.6% CAGR through 2030.
By geography, North America dominated with 37.2% 2024 revenue; Asia-Pacific is the fastest-growing region at 33.2% CAGR through 2030.

Global Vein Illuminator Market Trends and Insights

Drivers Impact Analysis

Driver	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
Rising first-attempt success rates for IV and phlebotomy	+8.5%	North America, Europe, global hospitals	Medium term (2-4 years)
Growth in chronic-disease blood draws	+7.2%	Asia-Pacific, North America	Long term (≥ 4 years)
Ageing and obese populations with difficult venous access	+6.8%	North America, Europe, emerging Asia-Pacific	Long term (≥ 4 years)
Hospital push for patient-experience KPIs	+4.3%	North America, Europe	Short term (≤ 2 years)
AI-integrated mobile vein-finder apps	+3.1%	Early adoption in North America	Medium term (2-4 years)
Adoption in cosmetic/aesthetic injections	+2.9%	North America, Europe	Medium term (2-4 years)

Source: Mordor Intelligence

Rising First-Attempt Success Rates Drive Quality Metrics

Clinical trials in pediatric units showed first-stick success climbing to 74.1% with AccuVein AV400 compared with 40.7% using palpation, trimming procedure time from 169 seconds to 44 seconds. ^{[2]Sevil Inal, “Impact of Peripheral Venous Catheter Placement With Vein Visualization Device Support on Success Rate and Pain Levels in Pediatric Patients,” Pediatric Emergency Care, researchgate.net} Health-system executives translate these gains directly into higher HCAHPS patient-experience scores, which shape Medicare reimbursements, elevating device purchases to strategic priorities. Patient surveys reveal 93% of respondents rate hospitals higher when staff employ visualization tools.

Growth in Chronic-Disease Blood Draws

More frequent HbA1c, lipid, and renal tests among diabetic and cardiovascular cohorts raise annual venipuncture volumes, stressing phlebotomy capacity. Aging vasculature and drug-induced vein fragility heighten failure risk, prompting facilities to equip labs with portable NIR finders that cut repeat sticks and consumable waste.

Ageing and Obese Populations Challenge Traditional Methods

Obese patients (BMI > 30) experienced a 3.5-fold jump in IV placement success when clinicians used NIR devices, reaching 96% success within two attempts for BMI > 40. Geriatric skin thinning and altered subcutaneous fat distribution compound access difficulty, moving nursing homes and bariatric centers to standardize visualization.

Hospital Push for Patient-Experience KPIs

U.S. value-based payment formulas directly link revenue to patient satisfaction, and vein illuminators measurably raise comfort scores. Maury Regional Health adopted a visualization system-wide to bolster HCAHPS metrics and reduce missed sticks.

Restraints Impact Analysis

Restraint	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
High capital and per-unit device costs	–4.8%	Emerging markets worldwide	Short term (≤ 2 years)
Lack of reimbursement codes	–3.2%	North America, Europe	Medium term (2-4 years)
Training gaps in low-resource settings	–2.1%	Asia-Pacific, Africa, Latin America	Long term (≥ 4 years)
Regulatory ambiguity for aesthetic-only devices	–1.9%	Global	Medium term (2-4 years)

Source: Mordor Intelligence

High Capital and Per-Unit Device Costs

Premium NIR systems list between USD 4,000 and USD 27,000, squeezing budgets of small hospitals. Experimental open-source models built from recycled optics have demonstrated comparable vein contrast for USD 25, hinting at future price erosion.

Lack of Reimbursement Codes

Because illumination is bundled into broader IV or phlebotomy codes, providers cannot recoup capital outlays directly. LimFlow’s 2025 CMS approval for a dedicated vascular device category signals that distinct coding pathways could emerge for visualizers.

Segment Analysis

By Technology: NIR Dominance Faces Hybrid Disruption

Near-Infrared Illumination controlled 50.3% revenue in 2024, underpinning the vein illuminator market with a mature, cost-efficient platform. Ultrasound-Augmented units, posting 31.8% CAGR to 2030, carve share in difficult-access patients via deeper imaging and synergy with existing ultrasound carts. Transillumination remains a pediatric niche due to softer light, while multispectral hybrids gain research traction. Patent filings such as the dual-mode VeinCAP system illustrate convergence trends toward single devices offering NIR plus diffuse hyperspectral views. ^{[4]Tandfonline, “VeinCAP: A Free-Hand Dual-Mode NIR-DHV Imaging Device,” tandfonline.com} As feature sets widen, vendors differentiate on AI algorithms that auto-grade vein quality and log success metrics to electronic health records.

By Product Type: Portability Drives Innovation

Hand-held and Portable devices occupied 61.2% of 2024 revenue because nurses favor pocketable tools that shift easily between wards. Wearable and Clip-On Modules, climbing at 34.1% CAGR, free clinicians’ hands during complex cannulations, and feed video to smart glasses for teaching. Table-top carts persist in blood banks where mounted cameras stay calibrated for long draws. IoT connectivity is redefining design priorities: next-generation wearables integrate Wi-Fi and cloud dashboards that benchmark first-stick rates, transforming basic lights into quality-management nodes.

By Application: Aesthetic Expansion Accelerates Growth

Intravenous Access held a 42.7% share in 2024, the base use case anchoring the vein illuminator market. Yet cosmetic practices fuel the fastest 32.5% CAGR in Sclerotherapy and Varicose Vein Treatment after FDA safety notices highlighted injection-site complication risks. Facial-vein mapping cuts bruising and hematoma rates, making imaging a standard of care in high-volume med-spa chains.

By End-user: Ambulatory Centers Drive Adoption

Hospitals and Clinics captured 46.1% revenue in 2024, but outpatient Ambulatory Surgical Centers are expanding fastest at 30.6% CAGR through 2030. Time-based reimbursement models reward ASC operators who shave minutes off IV setups with visualization, reinforcing spending despite tight capital budgets. Blood Donation Camps value donor comfort to secure repeat visits, while nursing homes purchase compact models that accompany mobile phlebotomy carts.

Geography Analysis

North America retained 37.2% 2024 revenue leadership on the back of sophisticated infrastructure and reimbursement programs that pay for patient-experience outcomes. U.S. hospitals embed first-stick statistics into quality dashboards, ensuring repeat device orders. Canada’s single-payer system favors province-wide contracts that lower per-unit costs, while Mexico’s private medical-tourism clinics install finders as patient-comfort differentiators.

Europe’s multi-payer environment produces steady uptake; Germany’s university hospitals pilot multi-modal units, and the United Kingdom’s NHS negotiates bulk pricing to support vascular-access safety goals. CE Mark harmonization smooths cross-border sales and encourages newer entrants from Scandinavia and Eastern Europe.

The vein illuminator market size in Asia-Pacific is expanding at a 33.2% CAGR, making it the global growth engine. India’s Production-Linked Incentive scheme subsidizes domestic device plants, reducing import reliance. China’s hospital-upgrade program requires equipment that boosts nursing efficiency; local brands undercut imports by bundling visualization with IV kits. Japan’s super-aged population and high device standards favor premium dual-mode systems, while South Korea’s start-ups test AI-enabled smartphone adapters for home infusion services.

Competitive Landscape

Market concentration is moderate: AccuVein, Christie Medical, and Translite together account for slightly less than half of global sales, while dozens of regional firms compete on price. Leaders defend their share through clinical evidence, 40-plus granted patents, and global distribution networks. Price competition is most acute in basic NIR models, where Asian OEMs ship sub-USD 500 units to community hospitals. Innovation is shifting toward platform propositions that pair imaging with analytics dashboards, cloud logbooks, and AI vein-grading. Strategic moves during 2024-2025 included Christie adding Bluetooth-enabled AVV-X series and AccuVein partnering with cloud-EHR vendors to auto-record cannulation attempts.

Consolidation is expected as firms seek scale for R&D and regulatory compliance. Likely buyers include infusion-therapy giants aiming to bundle visualization with IV set consumables, echoing Philips’ 2024 move to launch LumiGuide surgical navigation that embeds optics expertise within broader vascular portfolios. ^{[3]Koninklijke Philips N.V., “Philips LumiGuide: 3D Human GPS Powered by Light,” philips.com}

Vein Illuminator Industry Leaders

AccuVein Inc.
Christie Medical Holdings Inc.
TransLite LLC (Veinlite)
VueTek Scientific LLC
Venoscope LLC
*Disclaimer: Major Players sorted in no particular order

Vein Illuminator Market Concentration — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Need More Details on Market Players and Competitors?

Download PDF

Recent Industry Developments

January 2025: LimFlow received FDA approval and CMS payment codes for the TADV System, setting a coding precedent that could benefit visualization devices.
December 2024: Therma Bright signed a U.S. distribution agreement for Venowave VW5, underscoring distributor appetite for vascular-access tools.
December 2024: Inari Medical secured reimbursement for ClotTriever in Japan, illustrating Asia-Pacific’s willingness to pay for vascular innovation.
September 2024: Medical San obtained FDA clearance for the Liftendo laser varicose-vein system, expanding the interventional device pipeline.

Table of Contents for Vein Illuminator Industry Report

1. INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Rising first-attempt success rates for IV and phlebotomy
- 4.2.2 Growth in chronic-disease related blood draws
- 4.2.3 Ageing and obese populations with difficult venous access
- 4.2.4 Hospital push for patient-experience KPIs
- 4.2.5 AI-integrated mobile vein-finder apps
- 4.2.6 Adoption in cosmetic/aesthetic injections
4.3 Market Restraints
- 4.3.1 High capital and per-unit device costs
- 4.3.2 Lack of reimbursement codes
- 4.3.3 Training gaps in low-resource settings
- 4.3.4 Regulatory ambiguity for aesthetic-only devices
4.4 Industry Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Industry Attractiveness – Porter’s Five Forces Analysis
- 4.7.1 Bargaining Power of Suppliers
- 4.7.2 Bargaining Power of Buyers
- 4.7.3 Threat of New Entrants
- 4.7.4 Threat of Substitutes
- 4.7.5 Intensity of Competitive Rivalry
4.8 Impact of Macroeconomic Factors on the Market

5. MARKET SIZE AND GROWTH FORECASTS (VALUES)

5.1 By Technology
- 5.1.1 Near-Infrared (NIR) Illumination
- 5.1.2 Transillumination
- 5.1.3 Ultrasound-Augmented
- 5.1.4 Multispectral/Hybrid
- 5.1.5 Others
5.2 By Product Type
- 5.2.1 Hand-held and Portable
- 5.2.2 Table-Top/Cart-Mounted
- 5.2.3 Wearable and Clip-On Modules
5.3 By Application
- 5.3.1 Intravenous (IV) Access
- 5.3.2 Blood Draw/Venipuncture Assistance
- 5.3.3 Sclerotherapy and Varicose Vein Treatment
- 5.3.4 Emergency and Critical Care
- 5.3.5 Cosmetic/Aesthetic Injections
5.4 By End-user
- 5.4.1 Hospitals and Clinics
- 5.4.2 Blood Donation Camps and Blood Banks
- 5.4.3 Ambulatory Surgical Centers
- 5.4.4 Rehabilitation and Nursing Homes
- 5.4.5 Academic and Research Institutions
5.5 By Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 South America
- 5.5.2.1 Brazil
- 5.5.2.2 Argentina
- 5.5.2.3 Chile
- 5.5.2.4 Rest of South America
- 5.5.3 Europe
- 5.5.3.1 Germany
- 5.5.3.2 United Kingdom
- 5.5.3.3 France
- 5.5.3.4 Italy
- 5.5.3.5 Spain
- 5.5.3.6 Russia
- 5.5.3.7 Rest of Europe
- 5.5.4 Asia-Pacific
- 5.5.4.1 China
- 5.5.4.2 India
- 5.5.4.3 Japan
- 5.5.4.4 South Korea
- 5.5.4.5 Malaysia
- 5.5.4.6 Singapore
- 5.5.4.7 Australia
- 5.5.4.8 Rest of Asia-Pacific
- 5.5.5 Middle East and Africa
- 5.5.5.1 Middle East
- 5.5.5.1.1 United Arab Emirates
- 5.5.5.1.2 Saudi Arabia
- 5.5.5.1.3 Turkey
- 5.5.5.1.4 Rest of Middle East
- 5.5.5.2 Africa
- 5.5.5.2.1 South Africa
- 5.5.5.2.2 Nigeria
- 5.5.5.2.3 Rest of Africa

6. COMPETITIVE LANDSCAPE

6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
- 6.4.1 AccuVein Inc.
- 6.4.2 Christie Medical Holdings Inc.
- 6.4.3 TransLite LLC (Veinlite)
- 6.4.4 VueTek Scientific LLC
- 6.4.5 Venoscope LLC
- 6.4.6 Near Infrared Imaging Inc.
- 6.4.7 ZD Medical Inc.
- 6.4.8 VeinSight (Surmount Electronic)
- 6.4.9 Shenzhen Vivolight Medical Device and Technology Co.
- 6.4.10 Veincas Medical Ltd.
- 6.4.11 SIFSOF LLC
- 6.4.12 NextVein LLC
- 6.4.13 Infinium Medical Inc.
- 6.4.14 B. Braun Medical Inc.
- 6.4.15 Koninklijke Philips N.V.
- 6.4.16 Siemens Healthineers AG
- 6.4.17 Baxter International Inc.
- 6.4.18 GE Healthcare Technologies Inc.
- 6.4.19 Osang Healthcare Co., Ltd.
- 6.4.20 Kingmaker Biomedical Inc.
- 6.4.21 Dhanika Instrument Co.
- 6.4.22 Zhongke Micro-Light Medical Equipment Co.
- 6.4.23 YSENMED Medical Equipment Co.
- 6.4.24 Xavant Medical (Pty) Ltd.
- 6.4.25 ALEH Medical Laser and Systems
- 6.4.26 FY Medical Devices Co.

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

7.1 White-Space and Unmet-Need Assessment

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections

Get Price Break-up Now

Global Vein Illuminator Market Report Scope

Vein illumination devices use infrared technology to reveal the structure of the vein. The market for vein illumination device has witnessed a strong growth owing to various advantages offered by the devices, such as increased work efficiency, a decrease in the number of errors during the procedure, etc.

By Technology	Near-Infrared (NIR) Illumination
	Transillumination
	Ultrasound-Augmented
	Multispectral/Hybrid
	Others
By Product Type	Hand-held and Portable
	Table-Top/Cart-Mounted
	Wearable and Clip-On Modules
By Application	Intravenous (IV) Access
	Blood Draw/Venipuncture Assistance
	Sclerotherapy and Varicose Vein Treatment
	Emergency and Critical Care
	Cosmetic/Aesthetic Injections
By End-user	Hospitals and Clinics
	Blood Donation Camps and Blood Banks
	Ambulatory Surgical Centers
	Rehabilitation and Nursing Homes
	Academic and Research Institutions

By Geography	North America	United States
		Canada
		Mexico

	South America	Brazil
		Argentina
		Chile
		Rest of South America

	Europe	Germany
		United Kingdom
		France
		Italy
		Spain
		Russia
		Rest of Europe

	Asia-Pacific	China
		India
		Japan
		South Korea
		Malaysia
		Singapore
		Australia
		Rest of Asia-Pacific

	Middle East and Africa	Middle East	United Arab Emirates
			Saudi Arabia
			Turkey
			Rest of Middle East

		Africa	South Africa
			Nigeria
			Rest of Africa

By Technology

Near-Infrared (NIR) Illumination

Transillumination

Ultrasound-Augmented

Multispectral/Hybrid

Others

By Product Type

Hand-held and Portable

Table-Top/Cart-Mounted

Wearable and Clip-On Modules

By Application

Intravenous (IV) Access

Blood Draw/Venipuncture Assistance

Sclerotherapy and Varicose Vein Treatment

Emergency and Critical Care

Cosmetic/Aesthetic Injections

By End-user

Hospitals and Clinics

Blood Donation Camps and Blood Banks

Ambulatory Surgical Centers

Rehabilitation and Nursing Homes

Academic and Research Institutions

By Geography

North America	United States
	Canada
	Mexico
South America	Brazil
	Argentina
	Chile
	Rest of South America
Europe	Germany
	United Kingdom
	France
	Italy
	Spain
	Russia
	Rest of Europe
Asia-Pacific	China
	India
	Japan
	South Korea
	Malaysia
	Singapore
	Australia
	Rest of Asia-Pacific

Middle East and Africa	Middle East	United Arab Emirates
		Saudi Arabia
		Turkey
		Rest of Middle East

	Africa	South Africa
		Nigeria
		Rest of Africa

Need A Different Region or Segment?

Customize Now

Key Questions Answered in the Report

What is the current size of the vein illuminator market and its growth outlook?

The vein illuminator market size is USD 0.30 billion in 2025 and is projected to reach USD 1.04 billion by 2030, advancing at a 27.8% CAGR.

Which region is forecast to grow the fastest?

Asia-Pacific is expected to expand at a 33.2% CAGR through 2030, driven by medical-device manufacturing incentives in India and hospital modernization in China.

Which technology holds the largest market share?

Near-Infrared Illumination led with a 50.3% revenue share in 2024, supported by mature clinical validation and cost-efficient components.

Which end-user segment shows the highest growth rate?

Ambulatory Surgical Centers are growing the fastest with a 30.6% CAGR as outpatient care models prioritize shorter procedure times and higher patient satisfaction.

What are the primary factors accelerating adoption?

Higher first-attempt venipuncture success rates, rising chronic-disease blood draws, and hospital patient-experience KPIs are the leading demand drivers.

What key barriers restrain wider deployment?

High capital costs for premium devices and the absence of dedicated reimbursement codes reduce purchasing incentives, especially in cost-sensitive settings.

Page last updated on: June 21, 2025